Therapeutic Cancer Vaccines: The Next Frontier.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 3, p. 32
- By:
- Publication type:
- Article
Works matching IS 21644403 AND DT 2021 AND VI 11 AND IP 3
Results: 14
1
2
Ukoniq Approved for 2 Types of Lymphoma.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 3, p. 30
- Publication type:
- Article
3
FDA Approves Breyanzi for Advanced Large B-Cell Lymphoma.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 3, p. 30
- Publication type:
- Article
4
Empathy and an Open Mind: Design Thinking in Healthcare.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 3, p. 28
- By:
- Publication type:
- Article
5
Targeted Therapies in Cholangiocarcinoma.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 3, p. 25
- Publication type:
- Article
6
Umbralisib plus Ublituximab Regimen Superior to Chemoimmunotherapy in CLL.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 3, p. 24
- By:
- Publication type:
- Article
7
Asciminib Superior to Bosutinib in Chronic-Phase CML.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 3, p. 22
- By:
- Publication type:
- Article
8
Momelotinib Yields Long-Term Survival Benefit in Intermediate- or High-Risk Myelofibrosis.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 3, p. 20
- By:
- Publication type:
- Article
9
Glofitamab Step-Up Dosing Leads to High Response Rates in Relapsed or Refractory NHL.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 3, p. 18
- By:
- Publication type:
- Article
10
Encouraging Results Seen with Magrolimab plus Azacitidine in Unfit Patients with AML.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 3, p. 9
- By:
- Publication type:
- Article
11
Mosunetuzumab Offers Safe and Effective Treatment Option for Older Patients with DLBCL.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 3, p. 7
- By:
- Publication type:
- Article
12
Axicabtagene Ciloleucel Demonstrates Durable Clinical Benefit in High-Risk Large B-Cell Lymphoma.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 3, p. 1
- By:
- Publication type:
- Article
13
Digital Therapeutics in the Oncology Outpatient Setting.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 3, p. 1
- By:
- Publication type:
- Article
14
Novel RARA Agonist Combination Active in Relapsed or Refractory AML.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 3, p. 1
- By:
- Publication type:
- Article